Press release
Future Longevity Therapeutics Market Size to Reach US$ 43.72 Billion by 2033, Driven by Supplements and Anti-Aging Applications | DataM Intelligence
Future Longevity Therapeutics Market
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for Quick Response): https://www.datamintelligence.com/download-sample/longevity-therapeutics-market?sindhuri
North America Key Industry Developments (2026)
✅ June 2026: Elysium Health, Inc. expanded its healthy aging portfolio with next-generation cellular health supplements formulated to support NAD+ metabolism and mitochondrial function.
✅ April 2026: AgeX Therapeutics, Inc. reported progress in its regenerative medicine pipeline, advancing preclinical research focused on tissue rejuvenation and age-related disorders.
✅ February 2026: ProHealth, Inc. strengthened its direct-to-consumer presence by expanding digital wellness platforms and launching personalized longevity supplement programs across North America.
Asia-Pacific Key Industry Developments (2026)
✅ June 2026: Decode Age expanded its biological age testing and personalized longevity programs across Southeast Asia through new healthcare partnerships.
✅ May 2026: NanoSPACE announced the expansion of its longevity research collaborations with Japanese academic institutions to accelerate advanced anti-aging technologies.
✅ March 2026: Gataca introduced AI-powered personalized longevity assessment services in selected Asia-Pacific markets, supporting preventive health and healthy aging initiatives.
Key Mergers and Acquisitions (2026)
✅ Strategic Acquisition: T.A. SCIENCES acquired a precision nutrition company specializing in healthy aging formulations, expanding its science-based longevity product portfolio.
✅ Technology Partnership & Acquisition: Longevity by Nature completed the acquisition of a biotechnology startup focused on cellular rejuvenation technologies, strengthening its research capabilities in longevity therapeutics and personalized wellness solutions.
Buy Now & Unlock 360° Market Intelligence: :
https://www.datamintelligence.com/buy-now-page?report=longevity-therapeutics-market?sindhuri
Market Segmentation Analysis
By Product Type: Supplements dominate with 58.4% market share in 2024. Other therapeutics include advanced anti-aging compounds and personalized interventions.
By Application: Senescence inhibition, cardiovascular diseases, and cancer therapies drive demand for longevity therapeutics.
By Distribution Channel: Pharmacies, online channels, and retail stores remain primary distribution avenues, with online sales rapidly increasing.
Regional Insights
North America leads due to well-established nutraceutical infrastructure and high adoption of anti-aging therapeutics. Asia-Pacific is the fastest-growing region, driven by increasing consumer health awareness and government initiatives supporting nutraceutical and longevity research.
Growth Drivers
1. Rising global demand for anti-aging and healthspan-enhancing therapies
2. Expanding supplement and nutraceutical markets
3. Increasing prevalence of age-related diseases and chronic conditions
4. Technological advancements in senescence inhibition and regenerative therapies
5. Strategic partnerships and expansions by key players in North America and Asia-Pacific
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/longevity-therapeutics-market?sindhuri
Key Players
The market includes leading companies such as Decode Age, Zeroharm, Gataca, Longevity by Nature, ProHealth, Inc., Xandro Lab., NanoSPACE, AgeX Therapeutics, Inc., T.A. SCIENCES, and Elysium Health, Inc.
Key Highlights (Top 5 Key Players)
1. Elysium Health, Inc. - Expanding NAD+ supplement portfolio targeting age-related health.
2. AgeX Therapeutics, Inc. - Initiating advanced clinical trials for senescence-inhibiting therapies.
3. ProHealth, Inc. - Strengthening North American distribution through retail partnerships.
4. Decode Age - Scaling operations in Asia-Pacific via e-commerce collaborations.
5. NanoSPACE - Establishing R&D facilities in Japan for longevity therapeutics.
Unlock 360° Market Intelligence with DataM Intelligence Subscription Services:
https://www.datamintelligence.com/reports-subscription?sindhuri
Power your decisions with real time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape Analysis
✅ Company Profile Analysis
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updates
✅ Live Market & Pricing Trends
✅ Regulatory and Supply Chain Analysis
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us:
Sai Kiran
Business Development Manager
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology. Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Future Longevity Therapeutics Market Size to Reach US$ 43.72 Billion by 2033, Driven by Supplements and Anti-Aging Applications | DataM Intelligence here
News-ID: 4596685 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
2D Display Market Becomes a Strategic Watchpoint as embedded screens, industrial …
The Global 2D Display Market was valued at USD 2.99 billion in 2025 and is projected to reach USD 5.46 billion by 2035, expanding at a CAGR of 6.2% during 2026-2035, according to DataM Intelligence. The market is segmented by Type, Display Technology, Resolution, Panel Size, Display Type, Application and Region, reflecting demand across touch and non touch formats, LCD, LED, OLED and Micro-LED technologies, multiple resolution and panel size…
Super Apps Market Draws Enterprise Attention as payments, identity, commerce and …
The Super Apps Market is valued at US$159.07 billion in 2026 and is projected to reach US$1,551.79 billion by 2035, expanding at a CAGR of 28.8% during 2026-2035, according to DataM Intelligence. The market spans iOS, Android and other platforms, with applications across financial services, transportation & logistics services, e-commerce, social media & messaging and others, serving businesses and consumers across smartphones, tablets and other devices. This scale reflects a…
Steam Turbine Market (2031): Combined-Cycle, Cogeneration & Power Generation Gro …
DataM Intelligence has released a new research report titled "Steam Turbine Market Size 2026". The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the competitive landscape of leading industry players. It also highlights major growth drivers shaping the market, including rising electricity demand, increasing adoption of combined heat and power (CHP) systems, and growing demand for high-efficiency power-generation technologies. The report…
Functional Food Market: Asia Vita Foods(2026) & Partnership Opportunities Create …
The Global Functional Food Market Size was reached at US$ 233.70 billion in 2025 and is expected to reach US$ 378.00 billion by 2033, growing at a CAGR of 6.2% during the forecast period 2026-2033. The market is witnessing increasing demand as consumers look beyond basic nutrition and seek food products associated with gut health, immunity, cardiovascular wellness, sports nutrition, weight management, healthy aging, and overall well-being.
Could the right Functional…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
